Cold & Cough Remedies - Nigeria | Statista Market Forecast

In Nigeria, the revenue generated in the Cold & Cough Remedies market market in 2024 amounts to US$224.00m.
It is projected that the market will experience an annual growth rate of 14.34% (CAGR 2024-2029).
When compared to other countries around Worldwide, the United States generates the highest revenue in this market, with US$11.19bn in 2024.
In terms of per person revenues, US$0.98 is generated in 2024, taking into account the total population figures.
Nigeria's cold and cough remedies market is experiencing a surge in demand due to the country's high prevalence of respiratory illnesses.

Definition:
The Cold and Cough market comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies market in Nigeria has seen significant growth in recent years, driven by changing customer preferences, emerging trends in the market, and local special circumstances. Customer preferences in Nigeria have shifted towards natural and herbal remedies for cold and cough relief. This trend is in line with the global market, where consumers are increasingly seeking natural alternatives to traditional pharmaceutical products. The demand for natural remedies is driven by a growing awareness of the potential side effects of synthetic drugs and a desire for more holistic approaches to healthcare. As a result, there has been a surge in the popularity of herbal and Ayurvedic remedies in Nigeria, with consumers opting for products that are perceived to be safer and more sustainable.Trends in the market also reflect the changing demographics of Nigeria. With a young and growing population, there is a higher incidence of cold and cough among children and young adults. This has led to an increased demand for pediatric cold and cough remedies, including syrups, lozenges, and nasal sprays specifically formulated for children. Manufacturers have responded to this trend by introducing a wide range of child-friendly products, with flavors and packaging designed to appeal to younger consumers.Local special circumstances in Nigeria have also influenced the development of the Cold & Cough Remedies market. The country has a high prevalence of respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), which contribute to the demand for cold and cough remedies. Additionally, Nigeria experiences seasonal variations in temperature and humidity, which can exacerbate cold and cough symptoms. This has created a need for effective remedies that can provide relief in these conditions.Underlying macroeconomic factors have also played a role in the growth of the Cold & Cough Remedies market in Nigeria. The country has experienced steady economic growth in recent years, leading to an increase in disposable income and consumer spending. This has allowed consumers to prioritize their health and wellness, leading to greater demand for cold and cough remedies. Furthermore, the expansion of the retail sector, including the growth of e-commerce platforms, has made these products more accessible to a wider consumer base.In conclusion, the Cold & Cough Remedies market in Nigeria is developing in response to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The demand for natural and herbal remedies, the focus on pediatric products, the prevalence of respiratory diseases, and the increase in disposable income and consumer spending are all contributing to the growth of the market. As the market continues to evolve, manufacturers and retailers will need to adapt to these trends and cater to the specific needs and preferences of Nigerian consumers.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.